Crystalline interferon alpha for pulmonary delivery and method f

Details Crystalline interferon alpha for pulmonary delivery and method f Crystalline interferon alpha for pulmonary delivery and method f

1995-12-22

1999-10-26

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Lymphokine

424 854, 424 857, 530351, A61K 4505

Patent

active

059723319

ABSTRACT:
A method to prepare crystalline interferon alpha suitable for aerosol formulation either for systemic or topical (inhaled) drug delivery. The bioavailable interferon is in the form of crystalline submicrometer particles having a predetermined medium diameter.

REFERENCES:
patent: 2882203 (1959-04-01), Petersen et al.
patent: 4672108 (1987-06-01), Kung et al.
patent: 5441734 (1995-08-01), Reichert et al.
patent: 5460956 (1995-10-01), Reichert et al.
patent: 5503828 (1996-04-01), Testa et al.
Platz et al., Caplus # 192: 28202

Affiliated with

Also associated with

Rating

Crystalline interferon alpha for pulmonary delivery and method f does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline interferon alpha for pulmonary delivery and method f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline interferon alpha for pulmonary delivery and method f will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-760650